| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $3,179,628 ) |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA258337 | Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence | 000 | 5 | NIH | 12/12/2025 | $568,979 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01ES034250 | STAG2 modulates environmental toxicant exposures and epigenomic heterogeneity | 000 | 5 | NIH | 1/1/2026 | $597,213 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA266216 | Induction of interferon response by chromatin damaging anti-cancer therapy | 000 | 3 | NIH | 12/18/2025 | $357,193 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R37CA275961 | Targeting HNF1A-mediated therapeutic resistance in pancreatic ductal adenocarcinoma | 000 | 4 | NIH | 12/17/2025 | $470,879 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA296175 | A scalable cruciferous vegetable intervention to reduce bladder cancer recurrence and progression | 000 | 2 | NIH | 12/23/2025 | $597,807 |
| | 2026 | 2026 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA285707 | Determining the Impact of Metabolic Adaptations on the Immune-Tumor Microenvironment in Metastatic Breast Cancer | 000 | 2 | NIH | 12/19/2025 | $647,178 |
| | 2026 | 2025 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | U24CA305623 | Cancer Immunoprevention Network (CIP-Net) Resource Coordinating Center | 000 | 1 | NIH | 1/15/2026 | $0 |
| | 2026 | 2025 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R37CA248018 | Leveraging the GTP Biosynthetic Pathway for Anti-Tumor Therapies | 000 | 5 | NIH | 12/15/2025 | $0 |
| | 2026 | 2025 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01HL150266 | Inhibition of Radiation-Induced Coronary Microvascular Disease | 000 | 5 | NIH | 11/10/2025 | $0 |
| | 2026 | 2025 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA243456 | Radiogenomic Credentialing of Head and Neck Cancer Models | 000 | 5 | NIH | 11/18/2025 | $0 |
| | 2026 | 2025 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA252092 | Mechanisms of metabolic stress-induced transcriptional regulation in prostate cancer | 000 | 5 | NIH | 1/14/2026 | $0 |
| | 2026 | 2025 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA250412 | Impact of Circulating Myeloid Cell Clusters on Anti-Tumor Immunity | 000 | 5 | NIH | 11/25/2025 | $0 |
| | 2026 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA247281 | Tumor Immune Contexture and Breast Cancer Disparities: A Multi-Disciplinary Study in Women of African and European Ancestry | 000 | 5 | NIH | 12/8/2025 | $0 |
| | 2026 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | F30CA265127 | The impact of chronic stress on radiation induced cell death and the anti-tumor immune response | 000 | 4 | NIH | 12/31/2025 | -$9,408 |
| | 2026 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | C06OD037775 | ONE Biorepository: Comprehensive Integrated Biobanking Systems | 000 | 1 | NIH | 12/8/2025 | $0 |
| | 2026 | 2023 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | S10OD034359 | Acquisition of a calScreener Isothermal Microcalorimetry System for Translational Cancer Metabolism Research at Roswell Park | 000 | 1 | NIH | 12/5/2025 | -$6,581 |
| | 2026 | 2023 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R21CA267002 | Tumor and immune cell co-evolutionary dynamics as a source of racial disparities in breast cancer | 000 | 2 | NIH | 12/31/2025 | $0 |
| | 2026 | 2023 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R25CA181003 | Summer Research Experiences in Cancer Science and Oncology | 000 | 10 | NIH | 12/31/2025 | $0 |
| | 2026 | 2022 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA229415 | Enhancing Relapse Prevention with rTMS: Dose-Response Parameters for Smoking Cessation | 000 | 5 | NIH | 11/21/2025 | -$43,632 |
|
| Issue Date FY: 2025 ( Subtotal = $42,641,920 ) (Continued on the next page) |
| | 2025 | 2025 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R37CA248018 | Leveraging the GTP Biosynthetic Pathway for Anti-Tumor Therapies | 000 | 5 | NIH | 11/25/2024 | $345,191 |
| | 2025 | 2025 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | F30CA284763 | Understanding the role of β2AR-signaling on ILC2 differentiation/plasticity and its implications in cancer progression | 000 | 3 | NIH | 7/31/2025 | $54,538 |
| | 2025 | 2025 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R37CA282430 | Novel synthetic lethality strategy for TP53 mutant colorectal cancer | 000 | 3 | NIH | 8/5/2025 | $542,949 |
| | 2025 | 2025 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01DA057228 | Assessing pharmacokinetic and pharmacodynamic variability of Δ9-tetrahydrocannabinol delivered from vaping products with and without concurrent use of nicotine | 000 | 4 | NIH | 7/2/2025 | $651,235 |
| | 2025 | 2025 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01MD016850 | Implementation of evidence-based strategies to optimize HPV vaccination in rural primary care settings | 003 | 4 | NIH | 9/8/2025 | $661,573 |
| | 2025 | 2025 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA281862 | A Multi-Institute Survivorship Study of Patients Living with Advanced Cancer Who Have Had Durable Response to Immune Checkpoint Inhibitors | 001 | 3 | NIH | 8/21/2025 | $766,294 |
| | 2025 | 2025 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA278802 | TLR5 enhancement of liver-directed radiotherapy plus immune checkpoint blockade against irradiated liver metastasis and abscopal tumors | 001 | 3 | NIH | 5/29/2025 | $70,589 |
| | 2025 | 2025 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA278802 | TLR5 enhancement of liver-directed radiotherapy plus immune checkpoint blockade against irradiated liver metastasis and abscopal tumors | 000 | 3 | NIH | 4/24/2025 | $635,299 |
| | 2025 | 2025 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R37CA275961 | Targeting HNF1A-mediated therapeutic resistance in pancreatic ductal adenocarcinoma | 001 | 3 | NIH | 6/11/2025 | $51,887 |
| | 2025 | 2025 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R37CA275961 | Targeting HNF1A-mediated therapeutic resistance in pancreatic ductal adenocarcinoma | 000 | 3 | NIH | 11/27/2024 | $466,991 |
| | 2025 | 2025 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R50CA283761 | Development of New Technologies at Roswell Park to Further Cancer-Based Research and Treatment Through Genome Modification | 000 | 3 | NIH | 8/18/2025 | $324,868 |
| | 2025 | 2025 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA257480 | Transcriptomic classification of non-muscle invasive bladder cancer and its clinical and prognostic implication | 001 | 4 | NIH | 9/2/2025 | $2,683,351 |
| | 2025 | 2025 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA267690 | Targeting complement to enhance antitumor immunity and control malignant effusions in patients with recurrent epithelial ovarian cancer | 000 | 4 | NIH | 7/1/2025 | $642,760 |
| | 2025 | 2025 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | K08CA252161 | Therapeutic implication of RB1 loss in bladder cancer | 000 | 5 | NIH | 1/15/2025 | $285,729 |
| | 2025 | 2025 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA298812 | Assessing the impact of the substantial equivalence mechanism on the cigarette and cigar markets | 001 | 1 | NIH | 9/25/2025 | -$816,307 |
| | 2025 | 2025 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA298812 | Assessing the impact of the substantial equivalence mechanism on the cigarette and cigar markets | 000 | 1 | NIH | 9/12/2025 | $816,307 |
| | 2025 | 2025 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R50LM015262 | Investing in Research Software Engineering for Expert Development and Dissemination of Bioconductor | 000 | 1 | NIH | 9/11/2025 | $168,448 |
| | 2025 | 2025 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA298812 | Assessing the impact of the substantial equivalence mechanism on the cigarette and cigar markets | 001 | 1 | NIH | 9/25/2025 | $816,307 |
| | 2025 | 2025 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA251545 | Functional Significance of individual p53 mutations in determining the role of estrogen receptor beta in triple negative breast cancer | 001 | 5 | NIH | 5/22/2025 | $55,745 |
| | 2025 | 2025 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA251545 | Functional Significance of individual p53 mutations in determining the role of estrogen receptor beta in triple negative breast cancer | 000 | 5 | NIH | 2/13/2025 | $501,703 |
| | 2025 | 2025 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R37CA279440 | The Immunomodulatory Function of Cyclin E1 in Ovarian Cancer and Therapeutic Targeting | 001 | 2 | NIH | 5/22/2025 | $50,584 |
| | 2025 | 2025 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R37CA279440 | The Immunomodulatory Function of Cyclin E1 in Ovarian Cancer and Therapeutic Targeting | 000 | 2 | NIH | 3/10/2025 | $455,267 |
| | 2025 | 2025 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01AI155499 | Understanding mechanisms and consequences of T cell co-receptor regulated RNA maturation | 000 | 5 | NIH | 3/14/2025 | $501,412 |
| | 2025 | 2025 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | F30CA294838 | Genetic and Ancestral Determinants of Pathological and Molecular Tumor Immune Phenotypes in A Multi-Ethnic Population of Breast Cancer Patients: An Evolutionary Perspective | 000 | 1 | NIH | 8/25/2025 | $42,256 |
| | 2025 | 2025 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA272771 | The role of USP27X-Cyclin D1 axis in HER2 Therapy Resistant Breast Cancer | 001 | 3 | NIH | 5/22/2025 | $43,778 |
| | 2025 | 2025 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA255242 | Advancing skin cancer prevention by tackling UV-induced clonogenic mutations | 001 | 5 | NIH | 6/18/2025 | $64,033 |
| | 2025 | 2025 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA255242 | Advancing skin cancer prevention by tackling UV-induced clonogenic mutations | 000 | 5 | NIH | 2/14/2025 | $576,303 |
| | 2025 | 2025 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA292730 | Decipher the Molecular Mechanisms of Breast Cancer Bone Metastasis | 000 | 1 | NIH | 3/11/2025 | $700,690 |
| | 2025 | 2025 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01HD109750 | Generation and analysis of new mouse models to determine novel therapeutic targets for Down syndrome-associated cognitive deficits | 001 | 4 | NIH | 9/11/2025 | $116,033 |
|
